BCL2 Binding Component 3 (BBC3) (N-Term) Peptid
BBC3
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN973747
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 15 bis 22 Werktagen
Kurzübersicht für BCL2 Binding Component 3 (BBC3) (N-Term) Peptid (ABIN973747)
Target
PUMA (BBC3)
(BCL2 Binding Component 3 (BBC3))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Sequenz
- TTWVPCQICG PRERHGPRTP GGQLPGARRG PGPRRPAPLP ARPPGALGSV
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-BBC3 Antibody(ARP58945_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
BCL2 Binding Component 3 (BBC3) peptide (Ovalbumin)
BBC3 Reaktivität: Human Wirt: Synthetic WB, Imm, SDS
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PUMA (BBC3) (BCL2 Binding Component 3 (BBC3))
-
Hintergrund
-
BBC3 is an essential mediator of p53-dependent and p53-independent apoptosis.
Alias Symbols: FLJ42994, JFY1, PUMA, JFY-1
Protein Interaction Partner: BCL2,BAX,BCL2,BCL2,BCL2,BCL2A1,BCL2L1,BCL2L1,BCL2L1,BCL2L2,BNC1,MCL1,BAX,BCL2,BCL2A1,BCL2L1,BCL2L2,MCL1,BCL2,BCL2L1,MCL1
Protein Size: 261 -
Molekulargewicht
- 26 kDa
-
Gen-ID
- 27113
-
NCBI Accession
- NM_001127240, NP_001120712
-
UniProt
- Q96PG8
Target
-
Sie sind hier:
